Financials data is unavailable for this security.
View more
Year on year Taiflex Scientific Co Ltd 's revenues fell -6.55% from 8.72bn to 8.15bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 700.48m to 422.97m, a -39.62% decrease.
| Gross margin | 23.97% |
|---|---|
| Net profit margin | 7.27% |
| Operating margin | 8.79% |
| Return on assets | 4.92% |
|---|---|
| Return on equity | 8.78% |
| Return on investment | 6.86% |
More ▼
Cash flow in TWDView more
In 2023, cash reserves at Taiflex Scientific Co Ltd fell by 298.97m. However, the company earned 1.27bn from its operations for a Cash Flow Margin of 15.60%. In addition the company used 984.67m on investing activities and also paid 568.07m in financing cash flows.
| Cash flow per share | 4.40 |
|---|---|
| Price/Cash flow per share | 12.80 |
| Book value per share | 43.02 |
|---|---|
| Tangible book value per share | 42.35 |
More ▼
Balance sheet in TWDView more
| Current ratio | 1.86 |
|---|---|
| Quick ratio | 1.50 |
| Total debt/total equity | 0.2215 |
|---|---|
| Total debt/total capital | 0.1803 |
More ▼
Growth rates in TWD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -63.21% and -39.77%, respectively. Additionally when measured on a five year annualized basis, dividend per share growth is below the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 4.60% |
|---|---|
| Div growth rate (5 year) | -18.13% |
| Payout ratio (TTM) | 28.19% |
| EPS growth(5 years) | -11.51 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 103.36 |
More ▼
